Medical Devices Global

Global Rapid Antigen Tests Market Analysis, 2024–2034

Global Rapid Antigen Tests Market Industry Trends and Forecast to 2034: Segmented by (Disease, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.27 Bn Estimated value
Estimate 2025 $9.55 Bn Estimated value
Projected 2034 $12.46 Bn 30.5% Adds $2.91 Bn over 9 forecast years
CAGR 2025–2034 3.0% Faster than 0% of 173 Medical Devices markets here
Key players 5
  • Worldwide, the largest is US at $4.37 Bn.
  • Fastest growing: India at 6% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.91 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Rapid Antigen Tests Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.27 Bn — —
2025 (base) $9.55 Bn +$278.1 Mn —
2026 (forecast) $9.83 Bn +$286.4 Mn +3%
2027 (forecast) $10.13 Bn +$295.0 Mn +6.1%
2028 (forecast) $10.43 Bn +$303.9 Mn +9.3%
2029 (forecast) $10.75 Bn +$313.0 Mn +12.6%
2030 (forecast) $11.07 Bn +$322.4 Mn +15.9%
2031 (forecast) $11.40 Bn +$332.1 Mn +19.4%
2032 (forecast) $11.74 Bn +$342.0 Mn +23%
2033 (forecast) $12.10 Bn +$352.3 Mn +26.7%
2034 (forecast) $12.46 Bn +$362.9 Mn +30.5%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global (this report) $9.55 Bn
  2. North America $4.46 Bn
  3. US $4.37 Bn
  4. APAC $2.27 Bn
  5. Europe $1.73 Bn
  6. Canada $844.0 Mn
  7. China $845.1 Mn
  8. Japan $553.9 Mn
  9. Latin America $466.4 Mn
  10. Middle East $336.7 Mn
  11. Germany $297.9 Mn
  12. France $289.0 Mn
  13. UK $272.4 Mn
  14. Italy $242.9 Mn
  15. Brazil $246.7 Mn
  16. Ecuador $214.0 Mn
  17. Spain $173.8 Mn
  18. India $183.4 Mn
  19. Saudi Arabia $168.2 Mn
  20. Mexico $153.2 Mn
  21. Africa $142.8 Mn
  22. Australia $126.0 Mn
  23. New Zealand $99.5 Mn
  24. Russia $99.2 Mn
  25. South Africa $66.4 Mn
  26. UAE $49.1 Mn
  27. Egypt $30.3 Mn
  28. Philippines $18.2 Mn
  29. Malaysia $14.6 Mn
  30. Hong Kong $14.1 Mn
  31. Singapore $12.7 Mn
  32. Thailand $10.3 Mn
  33. Kenya $5.9 Mn

The Global Rapid Antigen Tests Market Analysis Executive Summary

Rapid antigen tests detect proteins from viruses or bacteria in minutes, used for flu, COVID-19, strep throat and more.

Key segments of the rapid Antigen Tests market include disease (Influenza, COVID-19 and Strep A) and user (Professional and Self-Test).

Global Rapid Antigen Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the rapid Antigen Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the rapid Antigen Tests market.

Competitive Landscape for Rapid Antigen Tests Market in Global

The rapid Antigen Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Rapid Antigen Tests Market in Global

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how rapid Antigen Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Rapid Antigen Tests right now, from free public sources.

Latest research 571 papers since 2021 (worldwide)

  1. Diagnostic performance of antigen-based rapid test kits for six respiratory viruses in children: comparison with a multiplex PCR panel and correlation with viral load. Journal of clinical microbiology, 2026
  2. Frequency and etiological agents of acute gastroenteritis in children: a retrospective analysis before and during the COVID-19 pandemic. BMC infectious diseases, 2026
  3. A Kawasaki Disease-Like Presentation in a Child with Concurrent Detection of Group A Streptococcus and Adenovirus: A Case Report on the Characterization of Physical Findings and Short-Interval Reassessment. Reports (MDPI), 2026
  4. Diagnostic yield of reflex multiplex PCR after a negative rapid antigen test in children hospitalized with presumed viral acute respiratory tract infection: a prospective cohort study. Irish journal of medical science, 2026
  5. Viral Respiratory Infections: COVID-19. FP essentials, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Rapid Antigen Tests in context

Questions, answered with public data

How much research is published on Rapid Antigen Tests?
PubMed lists 571 papers added since January 2021 that match this market, worldwide.[1]

[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Rapid Antigen Tests in Global? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Global

See all
Same topic, other categories

Related on diagnostics and lab testing and infectious diseases

See the topic